You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 13, October 6, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HIV Antibody Testing Among Those at Risk for Infection

The National AIDS Behavioral Surveys

Danie C. Berrios, MD, MPH; Norman Hearst, MD, MPH; Thomas J. Coates, PhD; Ronald Stall, PhD; Esther S. Hudes, PhD, MPH; Heather Turner, PhD; Rani Eversley, PhD; Joseph Catania, PhD

JAMA. 1993;270(13):1576-1580.


Abstract

Objective.
—To determine the prevalence of testing for human immunodeficiency virus (HIV) antibody among adults with various risk factors for infection, particularly those residing in large metropolitan areas where the bulk of cases of acquired immunodeficiency syndrome (AIDS) have occurred.

Design.
—A nationwide, population-based telephone survey eliciting testing, sexual, and injection drug use histories.

Participants.
—A total of 2673 randomly chosen US residents and 8263 randomly chosen residents of 23 metropolitan areas containing 64% of reported cases of AIDS.

Interventions.
—None.

Main Outcome Measure.
—Testing for HIV antibody.

Main Results.
—Overall, rates of individuals ever tested were only slightly higher in the urban areas (23%) than in the nation as a whole (21%). Testing frequencies were low among all risk groups (less than 40%), except men engaging in same-sex sexual activity (60%) and male and female injection drug users (46% and 73%, respectively). The low rate of testing (35%) among the largest risk group, heterosexual men and women engaging in unprotected sexual intercourse with multiple partners, was particularly worrisome.

Conclusions.
—To encourage antibody testing among the many at risk for infection who have not yet been tested, promotional campaigns should explain the universal susceptibility to infection among those at risk, and the availability of prophylactic medical therapies and social support services to persons who are HIV-seropositive. As there were comparable levels of risk-taking behavior among subjects in both samples, these campaigns must be designed to reach all segments of the population.

(JAMA. 1993;270:1576-1580)



Author Affiliations

From the Center for AIDS Prevention Studies, Division of General Internal Medicine, Department of Medicine (Drs Berrios, Hearst, Coates, Stall, Hudes, Turner, Eversley, and Catania), and the Department of Laboratory Medicine (Dr Berrios), University of California, San Francisco.


Footnotes

Reprint requests to Center for AIDS Prevention Studies, 74 New Montgomery St, Suite 600, San Francisco, CA 94105 (Dr Berrios).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV Testing and Receipt of Test Results Among Homeless Persons With Serious Mental Illness
Desai and Rosenheck
Am. J. Psychiatry 2004;161:2287-2294.
ABSTRACT | FULL TEXT  

Voluntary HIV testing in Europe
Renzi et al.
Scand J Public Health 2004;32:102-110.
ABSTRACT  

Home Access HIV Testing: What Took So Long?
Stryker and Coates
Arch Intern Med 1997;157:261-262.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.